The Association of TNF-α Promoter Polymorphisms with Genetic Susceptibility to Cervical Cancer in a Chinese Han Population

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Shanmugasundaram S, You J. Targeting persistent human papillomavirus infection. Viruses. 2017;9(8):229. doi:10.3390/v9080229
   PubMed Web of Science ®Google Scholar
• Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13(2):135–141. doi:10.1016/S1359-6101(01)00020-X
   PubMed Web of Science ®Google Scholar
• Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25(3):409–416. doi:10.1007/s10555-006-9005-3
   PubMed Web of Science ®Google Scholar
• Komori A, Yatsunami J, Suganuma M, et al. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res. 1993;53(9):1982–1985.
   PubMed Web of Science ®Google Scholar
• Duarte I, Santos A, Sousa H, et al. G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun. 2005;334(2):588–592. doi:10.1016/j.bbrc.2005.06.137
   PubMed Web of Science ®Google Scholar
• Du GH, Wang JK, Richards JR, Wang JJ. Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer. Int Immunopharmacol. 2019;66:154–161. doi:10.1016/j.intimp.2018.11.015
   PubMed Web of Science ®Google Scholar
• Singh H, Jain M, Sachan R, Mittal B. Association of TNFA (−308G>A) and IL-10 (−819C>T) promoter polymorphisms with risk of cervical cancer. Int J Gynecol Cancer. 2009;19(7):1190–1194. doi:10.1111/IGC.0b013e3181a3a3af
   PubMed Web of Science ®Google Scholar
• Behboodi N, Farazestanian M, Rastgar-Moghadam A, et al. Association of a variant in the tumor necrosis factor alpha gene with risk of cervical cancer. Mol Biol Rep. 2021;48(2):1433–1437. doi:10.1007/s11033-021-06185-4
   PubMed Web of Science ®Google Scholar
• Wang N, Yin D, Zhang S, et al. TNF-alpha rs1800629 polymorphism is not associated with HPV infection or cervical cancer in the Chinese population. PLoS One. 2012;7(9):e45246. doi:10.1371/journal.pone.0045246
   PubMed Web of Science ®Google Scholar
• Zidi S, Stayoussef M, Zouidi F, et al. Tumor necrosis factor alpha (−238/-308) and TNFRII-VNTR (−322) polymorphisms as genetic biomarkers of susceptibility to develop cervical cancer among tunisians. Pathol Oncol Res. 2015;21(2):339–345. doi:10.1007/s12253-014-9826-2
   PubMed Web of Science ®Google Scholar
• Babapour N, Mehramiz M, Rastgar Moghadam A, et al. Association of TNF-308 G>A polymorphism located in tumor necrosis factor a with the risk of developing cervical cancer and results of pap smear. J Cell Biochem. 2019;120(4):5444–5448. doi:10.1002/jcb.27823
   PubMed Web of Science ®Google Scholar
• Jang WH, Yang YI, Yea SS, et al. The −238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 2001;166(1):41–46. doi:10.1016/S0304-3835(01)00438-4
   PubMed Web of Science ®Google Scholar
• Li X, Yin G, Li J, et al. The correlation between tnf-α promoter gene polymorphism and genetic susceptibility to cervical cancer. Technol Cancer Res Treat. 2018;17:1533033818782793. doi:10.1177/1533033818782793
   Web of Science ®Google Scholar
• Duvlis S, Dabeski D, Cvetkovski A, Mladenovska K, Plaseska-Karanfilska D. Association of TNF-A (rs361525 and rs1800629) with susceptibility to cervical intraepithelial lesion and cervical carcinoma in women from Republic of North Macedonia. Int J Immunogenet. 2020;47(6):522–528. doi:10.1111/iji.12506
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO guidelines on malaria approved by the guidelines review committee; 2013.
   Google Scholar
• Li Z, Zhang Z, He Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the shesis. Cell Res. 2009;19(4):519–523. doi:10.1038/cr.2009.33
   PubMed Web of Science ®Google Scholar
• Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15(2):97–98. doi:10.1038/sj.cr.7290272
   PubMed Web of Science ®Google Scholar
• Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928–1929. doi:10.1093/bioinformatics/btl268
   PubMed Web of Science ®Google Scholar
• Calhoun ES, McGovern RM, Janney CA, et al. Host genetic polymorphism analysis in cervical cancer. Clin Chem. 2002;48(8):1218–1224. doi:10.1093/clinchem/48.8.1218
   PubMed Web of Science ®Google Scholar
• Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res. 2002;89(2):229–240. doi:10.1016/S0168-1702(02)00191-0
   PubMed Web of Science ®Google Scholar
• Madeleine MM, Johnson LG, Smith AG, et al. Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res. 2008;68(9):3532–3539. doi:10.1158/0008-5472.CAN-07-6471
   PubMed Web of Science ®Google Scholar
• Yang J, Liu W, Yan Z, et al. Polymorphisms in transporter associated with antigen presenting are associated with cervical intraepithelial neoplasia and cervical cancer in a Chinese Han population. HLA. 2021;98(1):23–36. doi:10.1111/tan.14333
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang J, Huang J, Tian Z. Tumor necrosis factor-alpha polymorphisms and cervical cancer: evidence from a meta-analysis. Gynecol Obstet Invest. 2020;85(2):153–158. doi:10.1159/000502955
   PubMed Web of Science ®Google Scholar
• Kroeger KM, Carville KS, Abraham LJ. The −308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997;34(5):391–399. doi:10.1016/S0161-5890(97)00052-7
   PubMed Web of Science ®Google Scholar
• de Moura EL, Dos santos ACM, da Silva DM, et al. Association of polymorphisms in cytokine genes with susceptibility to precancerous lesions and cervical cancer: a systematic review with meta-analysis. Immunol Invest. 2021;50(5):492–526. doi:10.1080/08820139.2020.1778023
   PubMed Web of Science ®Google Scholar
• Gadducci A, Guerrieri ME, Cosio S. Adenocarcinoma of the uterine cervix: pathologic features, treatment options, clinical outcome and prognostic variables. Crit Rev Oncol Hematol. 2019;135:103–114. doi:10.1016/j.critrevonc.2019.01.006
   PubMed Web of Science ®Google Scholar